HOME >> BIOLOGY >> NEWS
Two cholesterol-lowering statin drugs reduce another marker of coronary-artery disease

DALLAS Two out of three statins, powerful drugs lauded for dramatically lowering low-density lipoproteins (LDL) the bad cholesterol - have been found to significantly decrease another risk factor for coronary-artery disease, researchers at UT Southwestern Medical Center at Dallas reported.

In the first head-to-head comparison of the effect of three commonly prescribed statins on remnant lipoprotein (RLP) cholesterol levels, the researchers reported in todays issue of Arteriosclerosis, Thrombosis and Vascular Biology that atorvastatin (Lipitor) and simvastatin (Zocor) significantly reduced RLP levels. Pravastatin (Pravachol), the third drug used in the study, had no significant effect on RLP levels.

Remnant lipoproteins, particles that circulate in the bloodstream much like LDL cholesterol, promote plaque formation in the arteries and subsequently are independent risk factors of coronary-artery disease.

Given that RLPs are atherogenic and promote plaque formation, it is not unreasonable to attribute part of the benefit of statins in reducing cardiovascular events to the reduction in RLP levels, said Dr. Ishwarlal Jialal, professor of pathology and internal medicine at UT Southwestern and senior author of the study. Its clinically proven that statins lower LDL and reduce cardiovascular events. Results from this study provide evidence of another mechanism by which statins are beneficial.

Twenty-two patients with combined hyperlipidemia (LDL levels greater than 130 milligrams per deciliter and triglyceride levels between 160 and 600 mg/dL) randomly received 40 mg of pravastatin, 20 mg of simvastatin and 10 mg of atorvastatin for six weeks per medication. A three-week washout period followed the administration of each drug.

The RLP levels were tested using a novel assay that utilizes a gel containing specific antibodies, said Dr. Sridevi Devaraj, assistant professor of pathology. The antibodies bind to HDL and LDL, as well a
'"/>

Contact: Amy Shields
Amy.Shields@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
12-Dec-2001


Page: 1 2

Related biology news :

1. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
2. Soy isoflavones have a modest cholesterol-lowering effect in postmenopausal women
3. Genetic model for devastating form of paraplegia suggests new treatments
4. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
5. Vanderbilt doctors find citrus soda interacts with cyclosporine, maybe statins
6. Devastating parasitic weed may be felled by toxin borrowed from flies
7. Migraine mouse provides insight into neurobiology of devastating headaches
8. Rb proteins role in retina development is key to understanding devastating eye cancer
9. California pistachio industry threatened by potentially devastating disease
10. Endostatin also effective on head and neck cancers
11. Endostatin promising treatments for AIDS-related cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... ... February 05, 2019 , ... Amino Labs, a ... with MindFuel, a leading organization in educational science, technology, engineering and math (STEM) ... has pioneered a syn-bio starter kit for teachers – the Amino Labs ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... organization headquartered in Morrisville, NC, providing full, customizable clinical research services across ... to support educational programs for early stage life science entrepreneurs in the ...
(Date:1/25/2019)... ... January 24, 2019 , ... uBiome, the leader ... of Microbiology at the Jackson Laboratory (JAX), to its Scientific Advisory Board. Joining ... will bring to uBiome expertise in skin microbial interactions and probiotic treatments for ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... MabPlex International Ltd ... the global biopharmaceutical and biotechnology industries with sites in China and the United ... global investors lead by China's State Development & Investment Corporation (SDIC) and Shenzhen ...
(Date:1/30/2019)... ... January 30, 2019 , ... ... academia and governmental agencies to discuss best practices for laboratory automation and screening. ... , At this year’s conference, Visikol will be at booth #345 and ...
(Date:1/24/2019)... ... , ... Dr. Douglas Stramel of Advanced Care Veterinary Services in ... for nearly three years. A proponent of Regenerative Medicine, Dr. Stramel has ... using V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy kit that produces ...
(Date:1/20/2019)... ... 17, 2019 , ... Consumers are directing healthcare in many ... That's changing as many services now exist for patients to order tests without ... $208 million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer ...
Breaking Biology Technology:
Cached News: